1. Home
  2. BRSP vs ENGN Comparison

BRSP vs ENGN Comparison

Compare BRSP & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrightSpire Capital Inc.

BRSP

BrightSpire Capital Inc.

HOLD

Current Price

$6.06

Market Cap

736.9M

Sector

Real Estate

ML Signal

HOLD

Logo enGene Holdings Inc.

ENGN

enGene Holdings Inc.

HOLD

Current Price

$8.01

Market Cap

647.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRSP
ENGN
Founded
2017
1999
Country
United States
Canada
Employees
N/A
82
Industry
Real Estate Investment Trusts
Sector
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
736.9M
647.1M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BRSP
ENGN
Price
$6.06
$8.01
Analyst Decision
Buy
Buy
Analyst Count
3
6
Target Price
$6.50
$21.08
AVG Volume (30 Days)
700.0K
245.0K
Earning Date
04-28-2026
06-11-2026
Dividend Yield
10.60%
N/A
EPS Growth
75.24
N/A
EPS
N/A
N/A
Revenue
$330,587,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$17.54
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.77
$2.66
52 Week High
$6.17
$12.25

Technical Indicators

Market Signals
Indicator
BRSP
ENGN
Relative Strength Index (RSI) 64.80 53.86
Support Level $5.46 $7.83
Resistance Level $6.17 $8.14
Average True Range (ATR) 0.10 0.55
MACD 0.03 0.15
Stochastic Oscillator 93.64 54.89

Price Performance

Historical Comparison
BRSP
ENGN

About BRSP BrightSpire Capital Inc.

BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company mainstreaming genetic medicine through the delivery of therapeutics to mucosal tissues and other organs, with the goal of creating new ways to address diseases with high clinical needs, beginning with non-muscle invasive bladder cancer (NMIBC). The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Share on Social Networks: